MOUNT LAUREL, N.J., Oct. 31 /PRNewswire-FirstCall/ -- MedQuist Inc. today announced the appointment of Scott Bennett as its new senior vice president of Sales and Marketing. He will join MedQuist on November 1. Bennett comes to the company with more than 20 years of experience in the healthcare technology sales and marketing field, including a proven track record in developing and leading high performing sales and marketing organizations. Bennett will lead a newly integrated sales and marketing function, which MedQuist unveiled earlier this month.
Bennett was most recently the senior vice president of Sales and Marketing at Scheduling.com d/b/a SCI Solutions, Inc., where he rebuilt the company's marketing, sales and sales support infrastructure and processes, as well as helped lead the company to record revenue and profit growth. Prior to holding that position, Bennett was the vice president, Corporate Sales, at Siemens Medical Solutions, USA. During his tenure at Siemens, he led the regional sales teams to win and close the company's largest transactions, including negotiating the company's first Information Technology strategic alliance agreement. Bennett also spent 17 years with Shared Medical Systems in a variety of increasingly responsible sales and marketing leadership positions.
"I am excited to be joining the MedQuist team," says Bennett. "MedQuist is already the world leader of outsourced transcription services, and is positioned to play an even larger role in assisting health providers as they populate, safeguard and digitally transport patients' Electronic Health Records where and when they are needed. MedQuist is right at the forefront of the future of healthcare technology."
MedQuist, a member of the Philips Group of Companies, is a leading provider of electronic medical transcription, health information and document management products and services. MedQuist provides document workflow management, digital dictation, speech recognition, mobile dictation devices, Web-based transcription, electronic signature, medical coding products and outsourcing services.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such risks and uncertainties, which could cause actual results to differ from those contained in forward-looking statements include, but are not limited to: (1) our ability to recruit and retain qualified transcriptionists and other employees; (2) the impact of new services or products on the demand for our existing services; (3) our current dependence on medical transcription for substantially all of our business; (4) our ability to expand our customer base; (5) changes in law, including, without limitation, the impact the Health Information Portability and Accountability Act ("HIPAA") will have on our business; (6) infringement on the proprietary rights of others; (7) risks inherent in diversifying into other businesses; (8) any continuation of pricing pressures and declining billing rates; (9) difficulties relating to the implementation of management changes throughout the Company; (10) the outcome of pending and future legal and regulatory proceedings and investigations; and (11) any direct or indirect impact of the matters disclosed in the Form 12b-25 and Form 8-K filed by the Company on August 19, 2005. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
MedQuist Inc.CONTACT: Craig Martin of Feinstein Kean Healthcare, +1-617-761-6729,craig.martin@fkhealth.com
Web site: http://www.medquist.com/
